Powder: -20°C for 3 years | In solvent: -80°C for 1 year
(R)-(4′-Hydroxy)-5,7-dihydroxy-4-chromanone, an antiangiogenic homoisoflavonoid, exhibits activity against human retinal microvascular endothelial cells.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry |
Description | (R)-(4′-Hydroxy)-5,7-dihydroxy-4-chromanone, an antiangiogenic homoisoflavonoid, exhibits activity against human retinal microvascular endothelial cells. |
In vitro | (R)-(4′-Hydroxy)-5,7-dihydroxy-4-chromanone has an GI 50 value of 35.8 μM on proliferation of human retinal microvascular endothelial cells (HRECs)[1]. (R)-(4′-Hydroxy)-5,7-dihydroxy-4-chromanone (10 μM, 30 μM, and 100 μM; 8 hours) significantly decreases HRECs overall tubule formation and in a dose-dependent manner[1]. |
Molecular Weight | 286.28 |
Formula | C16H14O5 |
CAS No. | 849727-88-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(R)-(4′-Hydroxy)-5,7-dihydroxy-4-chromanone 849727-88-4 (R)(4′Hydroxy)5,7dihydroxy4chromanone (4′-Hydroxy)-5,7-dihydroxy-4-chromanone (R) (4′ Hydroxy) 5,7 dihydroxy 4 chromanone inhibitor inhibit